Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)

Recruiting Observational Study
Diabetes Type 1 Diabetes Diabetes Mellitus
Ready to participate?

Review the details below, then apply to join this clinical trial.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this postmarket clinical investigation is to evaluate the levels of glycemic control, quality of life, and satisfaction, as well as the patient experience, and acute diabetes complication rates provided by the Omnipod 5 Automated Insulin Delivery System (referred to as the Omnipod 5 System) in a real-world setting.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient with T1D aged ≥ 2 years. * Patient prescribed, less than a year ago, a commercially available confi guration of the Omnipod 5 System using a FreeStyle Libre 2 Plus sensor. * Patient has never used the Omnipod 5 System prior to inclusion. * Patient has not objected to t…
Contacts

Trang Ly, MBBS, PhD

978-600-7000

APClinical@insulet.com

CONTACT

Bonnie Dumais

978-600-7000

APClinical@insulet.com

CONTACT